Sub-threshold depression and antidepressants use in a community sample: searching anxiety and finding bipolar disorder

Table 3 Comparison of psychoactive drugs use and other treatments in Sub-threshold Depression (HRDS > 10 without criteria for lifetime Depressive Episode) = SD; subjects with Depressive Episode point prevalence = DE and in the overall sample without Depression (SD or DE) = ND

	2. SD	3. DE	1. ND	Overall Sample	Χ2 2DF	P
Total	137 (4.0)	55 (1.6)	3206 (94.3)	3398
°First line Antidepressants	20 (14.6)	17 (30.9)	69 (2.1)	106 (3.1)	210.2	0.0001
§Second line Antidepressants	7 (5.1)	14 (25.4)	32 (1.0)	53 (1.6)	14.7	0.0001
*Benzodiazepines	40 (29.1)	14 (25.4)	188 (5.8)	242 (7.1)	147.9	0.0001
°°Homeopathics	4 (2.9)	0	21 (0.6)	25 (0.7)	8.1	0.018
**Psychotherapies	13 (9.5)	8 (17.8)	50 (1.5)	71 (2.1)	95.3	0.0001

°Homogeneity by cells: 1vs2, χ2 = 74.1, 1DF P < 0.0001; 1vs3, χ2 = 205.7, 1DF P < 0.0001; 2vs3 χ2 = 9.8, 1DF 0.002; §Homogeneity by cells: 1vs2, χ2 = 12.5, 1DF P < 0.0001; 1vs3, χ2 = 76.3, 1DF P < 0.0001; 2vs3, χ2 = 14.6, P < 0.0001; 2vs3 χ2 = 5.6, 1DF P = 0.018; * Homogeneity by cells: 1vs2, χ2 = 109.4, 1DF P < 0.0001; 1vs3, χ2 = 44.5, 1DF P < 0.0001; 2vs3 χ2 = 0.1, 1DF NS; °° Homogeneity by cells: 1vs2, χ2 = 4.6, 1DF P < 0.031; 1vs3, χ2 = 0.1, 1DF NS; 2vs3 χ2 = 0.3, 1DF NS; ** Homogeneity by cells: 1vs2, χ2 = 40.4, 1DF P < 0.0001; 1vs3, χ2 = 45.0, 1DF P < 0.0001; 2vs3 χ2 = 0.5, 1DF NS

ISSN: 1471-244X